+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Does gelatin as a blood substitute selectively depress plasma fibronectin? A clinical randomized study



Does gelatin as a blood substitute selectively depress plasma fibronectin? A clinical randomized study



Der Anaesthesist 34(9): 470-473



In 18 adult patients, in a randomized way, 15 ml/kg of blood were replaced either by gelatin 5.5 pc or serum protein solution. 0,5, 4 and 24 h later there was only a significant difference between the two groups in total protein and serum albumin. The low molecular weight infection related proteins alpha-1-antitrypsin, immunoglobulin G and antithrombin III, as well as the high molecular weight proteins immunoglobulin M, plasma fibronectin and alpha-2-macroglobulin were at no time significantly different between the two groups. It is concluded that gelatin as a plasma substitute does not impair the opsonising effect of plasma fibronectin upon the reticuloendothelial system.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039860107

Download citation: RISBibTeXText

PMID: 3909842


Related references

Remarks on the article by F. Lackner et al.: Gelatin as a blood substitute depresses plasma fibronectin for 2 to 3 days after infusion. Der Anaesthesist 36(12): 698-699, 1987

Decrease of plasma fibronectin concentration following infusion of a gelatin-based plasma substitute in man. Scandinavian Journal of Clinical and Laboratory Investigation 44(6): 529-533, 1984

The fibronectin profile quantitation of fibronectin fibronectin gelatin binding activity and fibronectin inhibitor in normal human sera and plasma. Clinical Research 33(2 PART 1): 376A, 1985

Gelatin-binding domain-specific anti-human plasma fibronectin Fab' inhibits fibronectin-mediated gelatin binding but not cell spreading. Journal of Biological Chemistry 256(11): 5583-5587, 1981

Dissolved gelatin as a plasma substitute. 10 years of clinical use. Minerva Anestesiologica 41(11): 561-567, 1975

Clinical evaluation of the gelatin plasma substitute, Haemaccel. Wiadomosci Lekarskie 33(1): 1-5, 1980

Effect of fluorocarbon blood substitute on plasma fibronectin fn. Biomaterials Artificial Cells & Artificial Organs 15(2): 428, 1987

The influence of a gelatin plasma substitute haemaccel 35 on blood coagulation in dogs. European Journal of Pharmacology 183(5): 1837-1838, 1990

Preliminary experimental and clinical investigation of a new plasma substitute containing gelatin. European Surgical Research 2(2): 148, 1970

Gelatin solution as a plasma substitute in the treatment of shock from acute blood loss. American Journal of Surgery 78(3): 374-378, 1949

1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute. Schweizerische Medizinische Wochenschrift 101(27): 987-994, 1971

Renal function, blood volume reaction and hemostatic changes after an infusion of a plasma substitute with a gelatin base. Revista Brasileira de Anestesiologia 19(2): 260-270, 1969

Experimental study on modified fluid gelatin as a plasma substitute (2). Masui. Japanese Journal of Anesthesiology 18(10): 932-941, 1969

Clinical studies on possible side effects of a plasma substitute on the basis of gelatin (in spinal anesthesia). Infusionstherapie und Klinische Ernahrung 2(5): 353-354, 1975

Experimental study on modified fluid gelatin as a plasma substitute part 2. Japanese Journal Of Anesthesiology: 932-941, 1969